English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Michail Sarantis, Panagoula Kollia, Stavroula Samara, Helen Athanasopoulou, Yolanda Gyftodimou, Dimitra Lianou, Evdoxia Mpourazani, Artemis Doulgeraki 4 Department of Trauma and Orthopaedics, KAT Hospital, Athens, Greece; Department of Genetics & Biotechnology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece; Department of Bone and Mineral Metabolism, Institute of Child Health, Athens, Greece; Department of Clinical Genetics, Institute of Child Health, Athens, Greece; 1 Department of Pediatrics, “Aghia Sophia” Children’s Hospital, Athens, Greece

A new COL1A1 mutation in a Greek patient with osteogenesis imperfecta: Response to a low-dose protocol of zoledronic acid and two-year follow-up